Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Correction to: Detection of Mycobacterium tuberculosis in pediatric stool samples using TruTip technology.

Mesman AW, Soto M, Coit J, Calderon R, Aliaga J, Pollock NR, Mendoza M, Mestanza FM, Mendoza CJ, Murray MB, Lecca L, Holmberg R, Franke MF.

BMC Infect Dis. 2019 Oct 16;19(1):856. doi: 10.1186/s12879-019-4483-4.

2.

Urinary 1H NMR metabolomics profile of Italian citizens exposed to background levels of arsenic. A (pre)cautionary tale.

Locci E, Lecca LI, Piras R, Noto A, Pilia I, d'Aloja E, Campagna M.

Biomarkers. 2019 Oct 15:1-23. doi: 10.1080/1354750X.2019.1677777. [Epub ahead of print]

PMID:
31613149
3.

The JDCS Model and Blue-Collar Bullying: Decent Working Conditions for a Healthy Environment.

Finstad GL, Ariza-Montes A, Giorgi G, Lecca LI, Arcangeli G, Mucci N.

Int J Environ Res Public Health. 2019 Sep 14;16(18). pii: E3411. doi: 10.3390/ijerph16183411.

4.

High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: a prospective cohort study.

Calderon RI, Arriaga MB, Lopez K, Barreda NN, Sanabria OM, Fróes Neto JF, Araújo DN, Lecca L, Andrade BB.

BMC Infect Dis. 2019 Sep 11;19(1):799. doi: 10.1186/s12879-019-4416-2.

5.

Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis.

Aibana O, Huang CC, Aboud S, Arnedo-Pena A, Becerra MC, Bellido-Blasco JB, Bhosale R, Calderon R, Chiang S, Contreras C, Davaasambuu G, Fawzi WW, Franke MF, Galea JT, Garcia-Ferrer D, Gil-Fortuño M, Gomila-Sard B, Gupta A, Gupte N, Hussain R, Iborra-Millet J, Iqbal NT, Juan-Cerdán JV, Kinikar A, Lecca L, Mave V, Meseguer-Ferrer N, Montepiedra G, Mugusi FM, Owolabi OA, Parsonnet J, Roach-Poblete F, Romeu-García MA, Spector SA, Sudfeld CR, Tenforde MW, Togun TO, Yataco R, Zhang Z, Murray MB.

PLoS Med. 2019 Sep 11;16(9):e1002907. doi: 10.1371/journal.pmed.1002907. eCollection 2019 Sep.

6.

Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians.

Luo Y, Suliman S, Asgari S, Amariuta T, Baglaenko Y, Martínez-Bonet M, Ishigaki K, Gutierrez-Arcelus M, Calderon R, Lecca L, León SR, Jimenez J, Yataco R, Contreras C, Galea JT, Becerra M, Nejentsev S, Nigrovic PA, Moody DB, Murray MB, Raychaudhuri S.

Nat Commun. 2019 Aug 21;10(1):3765. doi: 10.1038/s41467-019-11664-1.

7.

Detection of Mycobacterium tuberculosis in pediatric stool samples using TruTip technology.

Mesman AW, Soto M, Coit J, Calderon R, Aliaga J, Pollock NR, Mendoza M, Mestanza FM, Mendoza CJ, Murray MB, Lecca L, Holmberg R, Franke MF.

BMC Infect Dis. 2019 Jun 27;19(1):563. doi: 10.1186/s12879-019-4188-8. Erratum in: BMC Infect Dis. 2019 Oct 16;19(1):856.

8.

Emotional Experiences of Mothers Living With HIV and the Quest for Emotional Recovery: A Qualitative Study in Lima, Peru.

Contreras C, Rumaldo N, Lindeborg MM, Mendoza M, Chen DR, Saldaña O, Wong M, Muñoz M, Schrier E, Lecca L, Castro A, Shin S, Nelson AK.

J Assoc Nurses AIDS Care. 2019 Jul-Aug;30(4):440-450. doi: 10.1097/JNC.0000000000000051.

PMID:
31241508
9.

Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study.

Yuen CM, Millones AK, Contreras CC, Lecca L, Becerra MC, Keshavjee S.

PLoS One. 2019 May 17;14(5):e0217104. doi: 10.1371/journal.pone.0217104. eCollection 2019.

10.

Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting.

Dixit A, Freschi L, Vargas R, Calderon R, Sacchettini J, Drobniewski F, Galea JT, Contreras C, Yataco R, Zhang Z, Lecca L, Kolokotronis SO, Mathema B, Farhat MR.

Sci Rep. 2019 Apr 3;9(1):5602. doi: 10.1038/s41598-019-41967-8.

11.

Education and Training in Global Occupational Health and Safety: A Perspective on New Pathways to Sustainable Development.

Paganelli M, Madeo E, Nabeel I, Pilia I, Lecca LI, Pili S, Fostinelli J.

Ann Glob Health. 2018 Oct 10;84(3):538-540. doi: 10.29024/aogh.2309.

12.

Dynamics of Treatment Supporters and Patients Starting HIV Therapy in Lima, Peru.

Harishankar K, Wong M, Saldana O, Santa Cruz J, Lecca L, Munoz M, Nelson AK, Castro A, Shin S.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218824310. doi: 10.1177/2325958218824310.

PMID:
30798674
13.

Emotional Experiences of Mothers Living With HIV and the Quest for Emotional Recovery: A Qualitative Study in Lima, Peru.

Contreras C, Rumaldo N, Lindeborg MM, Mendoza M, Chen DR, Saldaña O, Wong M, Muñoz M, Schrier E, Lecca L, Castro A, Shin S, Nelson AK.

J Assoc Nurses AIDS Care. 2019 Feb 13. doi: 10.1097/JNC.0000000000000051. [Epub ahead of print]

PMID:
30768433
14.

Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru.

Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB.

BMC Pulm Med. 2019 Feb 13;19(1):40. doi: 10.1186/s12890-019-0804-z.

15.

Using Changes in Weight-for-Age z Score to Predict Effectiveness of Childhood Tuberculosis Therapy.

Chiang SS, Park S, White EI, Friedman JF, Cruz AT, Del Castillo H, Lecca L, Becerra MC, Seddon JA.

J Pediatric Infect Dis Soc. 2019 Feb 1. doi: 10.1093/jpids/piy138. [Epub ahead of print]

PMID:
30715497
16.

Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.

Velásquez GE, Brooks MB, Coit JM, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Lecca L, Davies GR, Mitnick CD.

Am J Respir Crit Care Med. 2019 May 1;199(9):1167-1168. doi: 10.1164/rccm.201812-2281LE. No abstract available.

17.

Feasibility of the string test for tuberculosis diagnosis in children between 4 and 14 years old.

Tafur KT, Coit J, Leon SR, Pinedo C, Chiang SS, Contreras C, Calderon R, Mendoza MJ, Lecca L, Franke MF.

BMC Infect Dis. 2018 Nov 15;18(1):574. doi: 10.1186/s12879-018-3483-0.

18.

Work Related Stress, Well-Being and Cardiovascular Risk among Flight Logistic Workers: An Observational Study.

Lecca LI, Campagna M, Portoghese I, Galletta M, Mucci N, Meloni M, Cocco P.

Int J Environ Res Public Health. 2018 Sep 7;15(9). pii: E1952. doi: 10.3390/ijerph15091952.

19.

Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis.

Peloquin CA, Phillips PPJ, Mitnick CD, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Kaur P, Horsburgh CR Jr.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00770-18. doi: 10.1128/AAC.00770-18. Print 2018 Oct.

20.

Automated TruTip nucleic acid extraction and purification from raw sputum.

Thakore N, Norville R, Franke M, Calderon R, Lecca L, Villanueva M, Murray MB, Cooney CG, Chandler DP, Holmberg RC.

PLoS One. 2018 Jul 5;13(7):e0199869. doi: 10.1371/journal.pone.0199869. eCollection 2018.

21.

Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.

Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):657-666. doi: 10.1164/rccm.201712-2524OC.

22.

Composition of Metallic Elements and Size Distribution of Fine and Ultrafine Particles in a Steelmaking Factory.

Marcias G, Fostinelli J, Catalani S, Uras M, Sanna AM, Avataneo G, De Palma G, Fabbri D, Paganelli M, Lecca LI, Buonanno G, Campagna M.

Int J Environ Res Public Health. 2018 Jun 7;15(6). pii: E1192. doi: 10.3390/ijerph15061192.

23.

CASITA: a controlled pilot study of community-based family coaching to stimulate early child development in Lima, Peru.

Nelson AK, Miller AC, Munoz M, Rumaldo N, Kammerer B, Vibbert M, Lundy S, Soplapuco G, Lecca L, Condeso A, Valdivia Y, Atwood SA, Shin SS.

BMJ Paediatr Open. 2018 May 26;2(1):e000268. doi: 10.1136/bmjpo-2018-000268. eCollection 2018. Erratum in: BMJ Paediatr Open. 2018 Jun 6;2(1):e000268corr1.

24.

Vitamin E Status Is Inversely Associated with Risk of Incident Tuberculosis Disease among Household Contacts.

Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Contreras C, Yataco R, Lecca L, Murray MB.

J Nutr. 2018 Jan 1;148(1):56-62. doi: 10.1093/jn/nxx006.

25.

Genotyping Multidrug-Resistant Mycobacterium tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray Test.

Linger Y, Knickerbocker C, Sipes D, Golova J, Franke M, Calderon R, Lecca L, Thakore N, Holmberg R, Qu P, Kukhtin A, Murray MB, Cooney CG, Chandler DP.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01652-17. doi: 10.1128/JCM.01652-17. Print 2018 Mar.

26.

Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.

Shu E, Sobieszczyk ME, Sal Y Rosas VG, Segura P, Galea JT, Lecca L, Sanchez J, Lama JR.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1288-1293. doi: 10.5588/ijtld.17.0116.

PMID:
29297450
27.

Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.

Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):86-92. doi: 10.5588/ijtld.17.0381.

PMID:
29297431
28.

Mental disorders and drug/alcohol use in patients commencing extensively drug-resistant tuberculosis treatment.

Scuffell J, Boccia D, Garcia Velarde F, Leon SR, Raviola G, Lecca L, Galea JT.

Public Health Action. 2017 Sep 21;7(3):237-239. doi: 10.5588/pha.17.0044.

29.

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.

Bouton TC, Phillips PPJ, Mitnick CD, Peloquin CA, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Horsburgh CR Jr.

Trials. 2017 Nov 25;18(1):563. doi: 10.1186/s13063-017-2292-x.

30.

Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.

Nathavitharana RR, Shi CX, Chindelevitch L, Calderon R, Zhang Z, Galea JT, Contreras C, Yataco R, Lecca L, Becerra MC, Murray MB, Cohen T.

Emerg Infect Dis. 2017 Nov;23(11):1887-1890. doi: 10.3201/eid2311.170077.

31.

Development and Validation of a Food Frequency Questionnaire to Estimate Intake among Children and Adolescents in Urban Peru.

Rodriguez CA, Smith ER, Villamor E, Zavaleta N, Respicio-Torres G, Contreras C, Perea S, Jimenez J, Tintaya K, Lecca L, Murray MB, Franke MF.

Nutrients. 2017 Oct 14;9(10). pii: E1121. doi: 10.3390/nu9101121.

32.

Protective effects of household-based TB interventions are robust to neighbourhood-level variation in exposure risk in Lima, Peru: a model-based analysis.

Zelner J, Murray M, Becerra M, Galea J, Lecca L, Calderon R, Yataco R, Zhang Z, Cohen T.

Int J Epidemiol. 2018 Feb 1;47(1):185-192. doi: 10.1093/ije/dyx171.

PMID:
29025111
33.

Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".

Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito ES, Vasquez DV, Mitnick CD, Davies G.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01524-17. doi: 10.1128/AAC.01524-17. Print 2017 Sep. No abstract available.

34.

Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.

Calderón RI, Velásquez GE, Becerra MC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Kritski AL, Murray MB, Mitnick CD.

Int J Tuberc Lung Dis. 2017 Aug 1;21(8):894-901. doi: 10.5588/ijtld.16.0850.

35.

Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis.

Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB.

ERJ Open Res. 2017 Jul 12;3(3). pii: 00026-2017. doi: 10.1183/23120541.00026-2017. eCollection 2017 Jul.

36.

Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.

Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Sanchez Garavito E, Vargas Vasquez D, Mitnick CD, Davies G.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00038-17. doi: 10.1128/AAC.00038-17. Print 2017 Aug. Erratum in: Antimicrob Agents Chemother. 2017 Aug 24;61(9):.

37.

Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.

Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Ronnenberg AG, Contreras C, Yataco R, Lecca L, Murray MB.

Clin Infect Dis. 2017 Sep 15;65(6):900-909. doi: 10.1093/cid/cix476.

38.

Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.

Lecca L, Galea J, Contreras CC, Millones AK, Clendenes M, Yuen CM.

AIDS. 2017 Jun 1;31(9):1207-1209. doi: 10.1097/QAD.0000000000001471. No abstract available.

PMID:
28492390
39.

Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.

Chiang SS, Roche S, Contreras C, Del Castillo H, Canales P, Jimenez J, Tintaya K, Becerra MC, Lecca L.

Int J Tuberc Lung Dis. 2017 Feb 1;21(2):154-160. doi: 10.5588/ijtld.16.0624.

PMID:
28234078
40.

Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e00069-17. doi: 10.1128/AAC.00069-17. Print 2017 Mar. No abstract available.

41.

Addressing tuberculosis patients' medical and socio-economic needs: a comprehensive programmatic approach.

Contreras CC, Millones AK, Santa Cruz J, Aguilar M, Clendenes M, Toranzo M, Llaro K, Lecca L, Becerra MC, Yuen CM.

Trop Med Int Health. 2017 Apr;22(4):505-511. doi: 10.1111/tmi.12844. Epub 2017 Feb 20.

42.

Community-Based Accompaniment with Supervised Antiretrovirals for HIV-Positive Adults in Peru: A Cluster-Randomized Trial.

McLaughlin MM, Franke MF, Muñoz M, Nelson AK, Saldaña O, Cruz JS, Wong M, Zhang Z, Lecca L, Ticona E, Arevalo J, Sanchez E, Sebastián JL, Shin S.

AIDS Behav. 2018 Jan;22(1):287-296. doi: 10.1007/s10461-017-1680-2.

43.

Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts.

Aibana O, Acharya X, Huang CC, Becerra MC, Galea JT, Chiang SS, Contreras C, Calderon R, Yataco R, Velásquez GE, Tintaya K, Jimenez J, Lecca L, Murray MB.

PLoS One. 2016 Nov 11;11(11):e0166333. doi: 10.1371/journal.pone.0166333. eCollection 2016.

44.

Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6766-6773. doi: 10.1128/AAC.00632-16. Print 2016 Nov. Erratum in: Antimicrob Agents Chemother. 2017 Feb 23;61(3):.

45.

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.

Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M, Coleman D, Osso E, Coit J, Vargas Vasquez DE, Sanchez Garavito E, Calderon R, Contreras C, Davies G, Mitnick CD.

BMC Infect Dis. 2016 Aug 27;16(1):453. doi: 10.1186/s12879-016-1790-x.

46.

Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.

Chiang SS, Starke JR, Miller AC, Cruz AT, Del Castillo H, Valdivia WJ, Tunque G, García F, Contreras C, Lecca L, Alarcón VA, Becerra MC.

Clin Infect Dis. 2016 Oct 15;63(8):1063-71. doi: 10.1093/cid/ciw489. Epub 2016 Jul 25.

PMID:
27458026
47.

Metabolomic patterns associated to QTc interval in shiftworkers: an explorative analysis.

Campagna M, Locci E, Piras R, Noto A, Lecca LI, Pilia I, Cocco P, d'Aloja E, Scano P.

Biomarkers. 2016 Nov;21(7):607-13. doi: 10.3109/1354750X.2016.1171900. Epub 2016 Apr 28.

48.

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants.

Odone A, Calderon R, Becerra MC, Zhang Z, Contreras CC, Yataco R, Galea J, Lecca L, Bonds MH, Mitnick CD, Murray MB.

PLoS One. 2016 Jan 14;11(1):e0146642. doi: 10.1371/journal.pone.0146642. eCollection 2016.

49.

Barriers to the diagnosis of childhood tuberculosis: a qualitative study.

Chiang SS, Roche S, Contreras C, Alarcón V, Del Castillo H, Becerra MC, Lecca L.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1144-52. doi: 10.5588/ijtld.15.0178.

PMID:
26459524
50.

Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data.

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Manjourides J, Grenfell BT, Cohen T.

J Infect Dis. 2016 Jan 15;213(2):287-94. doi: 10.1093/infdis/jiv387. Epub 2015 Jul 14.

Supplemental Content

Support Center